This Summit will focus on Sudden Cardiac Death as a key topic for the global EP community.  Two sessions with panel discussions with speakers and content expert moderators will be offered.  The first session highlights the global landscape with speakers discussing the current state of SCD including data, management, resources, and gaps from each region. The second session will focus on strategies, including novel and problem-solving ideas as we work to implement change in our global approach to SCD.   

• Understand differences in approach, resources, and gaps in SCD around the globe.
• Learn strategies for addressing SCD early detection, resuscitation, and management.

• To exchange knowledge between members of the Global EP community and HRS.
• To identify opportunities to improve patient care through a global lens.

Mervat Aboulmaaty Nabih, MD | Ain Shams University 
Nothing to disclose.

Elijah Behr, MA, MBBS, MD | City St George`s , University of London 
Honoraria/Speaking/Consulting: Boston Scientific, Solid Bioscience

Julia Cadrin-Tourigny, MD, PhD, CCDS | Montreal Heart Institute 
Honoraria/Speaking/Consulting: Tenaya Therapeutics, LEXEO Therapeutics, INc., BioMarin, Inc.

Jong-Il Choi, MD, MHS, MS, PhD | Korea University Hospital 
Nothing to disclose. 

Mina K. Chung, MD, FHRS | Cleveland Clinic, Department of Cardiology 
Research: NIH, American Heart Association
Royalty Income: Elsevier, Wolters Kluver
Honoraria/Speaking/Consulting: University of Chicago, Cedars Sinai Medical Center, APHRS, NIH, Baylor College of Medicine, Kansas City Heart Rhythm Symposium, American College of Cardiology, Geisinger Health Systems, ABIM, Academy for Continued Healthcare Learning, Mediasphere Medical, Western AF Symposium, University of Minnesota, Stanford University, Canadian Heart Rhythm Society
Membership on Advisory Committees: American Heart Association
Other Non-Financial Relationships: France ANR
Other Financial Relationships: American Heart Association

Sumeet S. Chugh, MD, FHRS | Cedars-Sinai, Los Angeles 
Research: NIH
Stocks (Publicly Traded): Alphabet, Inc., Apple, Inc., Microsoft, Amazon

Andrew M. Davis, MBBS, MD, FHRS, CEPS-P | Royal Children`s Hospital 
Nothing to disclose.

Cameron Dezfulian, MD, FAHA | Texas Children's Hospital, Baylor College of Medecine
Nothing to disclose.

Andrew D. Krahn, MD, FHRS | Division of Cardiology, University of British Columbia 
Honoraria/Speaking/Consulting: Medtronic, Inc., Tenaya Therapeutics

Carolina Malta-Hansen, MD, PhD | Klinisk Forskningslektor 
Honoraria/Speaking/Consulting: Other
Research: Other

Christina Y. Miyake, MD, MPH, MS | Texas Children's Hospital
Nothing to disclose. 

Pyotr G. Platonov, MD, PhD, FHRS | Lund University
Honoraria/Speaking/Consulting: Pfizer, Inc.
Membership on Advisory Committees: Tenaya Therapeutics

Pieter Gerard Postema, MD, PhD | Amsterdam University Medical Centers 
Research: Dutch Heart Foundation

Eduardo B. Saad, MD, PhD, FHRS | Hospital Samaritano 
Honoraria/Speaking/Consulting: Biosense Webster, Inc., Abbott

Luciana Sacilotto, MD, PhD | Instituto do Coração - HCFMUSP 
Nothing to disclose.

Kyoko Soejima, MD | Kyorin University School of Medicine
Honoraria/Speaking/Consulting: Medtronic Japan, Abbott Japan, Boehringer Ingelheim, Daiichi Sankyo, Boston Scientific Japan

Gregory Webster, MD, MPH | Lurie Children`s Hospital 
Research: NIH/NHLBI, Brett Boyer Foundation

 

 

Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet enduring activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification (MOC) Statement 

Successful completion of this ACE activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of ACE credits claimed for the activity. It is the ACE activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABP Maintenance of Certification (MOC) Statement 

Successful completion of this ACE activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the ACE activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Royal College of Physicians and Surgeons of Canada MOC Recognition Statement
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “ACE in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Other Credit Available
A Credit Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:
·         American Academy of Family Physicians (AAFP) (for elective credit)
·         American Academy of Nurse Practitioners Certification Board (AANPCB)
·         American Academy of Physician Assistants (AAPA)
·         American Nurses Credentialing Center (ANCC)
·         American Osteopathic Association (AOA) (for Category 2 credit)
·         Committee on Accreditation of Continuing Medical Education (Canada)
·         European Board for Accreditation in Cardiology (EBAC)
·         European CME Credits (ECMEC)
·         German Chambers of Physicians
·         National Society of Genetic Counselors (for Category 2 credit)
·         Oman Medical Specialty Board
·         Qatar Council for Healthcare Practitioners
·         Royal College of Physicians and Surgeons of Canada (RCPSC)

ACE Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.


Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.


Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.


ACCME Definition:

*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:

Advertising, marketing, or communication firms whose clients are ineligible companies
Bio-medical startups that have begun a governmental regulatory approval process
Compounding pharmacies that manufacture proprietary compounds
Device manufacturers or distributors
Diagnostic labs that sell proprietary products
Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
Manufacturers of health-related wearable products
Pharmaceutical companies or distributors
Pharmacy benefit managers
Reagent manufacturers or sellers


All relevant financial relationships have been mitigated.
Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
G Bird: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.
S. Sailor: No relevant financial relationships with ineligible companies to disclose.
M. Anderson: No relevant financial relationships with ineligible companies to disclose.